Waldencast plc Class A Ordinary Share
WALDWaldencast plc is a global beauty and wellness company focused on acquiring, building, and growing prestige brands. It emphasizes innovative and consumer-centric products within the skincare, haircare, and fragrance segments, aiming to establish a diverse portfolio of leading brands through strategic acquisitions and development.
Company News
Obagi Medical presented new clinical research at the 2025 American Society for Dermatologic Surgery Annual Meeting, highlighting pivotal studies on hyaluronic acid fillers and a scalp serum, demonstrating promising results in midface augmentation and scalp health.
Waldencast has acquired Novaestiq Corp. and the U.S. rights to the Saypha® injectable hyaluronic acid gel line, expanding Obagi Medical's portfolio into dermal fillers and positioning the company at the intersection of skincare and aesthetic treatments.
The consensus price target hints at a 26% upside potential for Waldencast PLC (WALD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
